IN2014DN08407A - - Google Patents

Info

Publication number
IN2014DN08407A
IN2014DN08407A IN8407DEN2014A IN2014DN08407A IN 2014DN08407 A IN2014DN08407 A IN 2014DN08407A IN 8407DEN2014 A IN8407DEN2014 A IN 8407DEN2014A IN 2014DN08407 A IN2014DN08407 A IN 2014DN08407A
Authority
IN
India
Prior art keywords
methods
compositions
immunostimulatory cell
cell compositions
activated immunostimulatory
Prior art date
Application number
Inventor
Irene Ginis
Alan Smith
Marina Bubis
Mitchell Shirvan
Original Assignee
Macrocure Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Macrocure Ltd filed Critical Macrocure Ltd
Publication of IN2014DN08407A publication Critical patent/IN2014DN08407A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/464838—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • AIDS & HIV (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Methods of making activated immunostimulatory cell compositions activated immunostimulatory cell compositions and methods of using those compositions to stimulate therapeutic immune responses to infectious organisms are described.
IN8407DEN2014 2012-03-15 2013-03-13 IN2014DN08407A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261611180P 2012-03-15 2012-03-15
PCT/IB2013/000935 WO2013136191A1 (en) 2012-03-15 2013-03-13 Activated immunostimulatory cell composition for therapy of infection

Publications (1)

Publication Number Publication Date
IN2014DN08407A true IN2014DN08407A (en) 2015-05-08

Family

ID=48483110

Family Applications (1)

Application Number Title Priority Date Filing Date
IN8407DEN2014 IN2014DN08407A (en) 2012-03-15 2013-03-13

Country Status (8)

Country Link
US (1) US20150071892A1 (en)
EP (1) EP2825182A1 (en)
JP (1) JP2015509974A (en)
CA (1) CA2864838A1 (en)
IN (1) IN2014DN08407A (en)
MX (1) MX2014010893A (en)
RU (1) RU2014140795A (en)
WO (1) WO2013136191A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012032418A2 (en) 2010-09-09 2012-03-15 Macrocure, Ltd. Activated leukocyte conditioned supernatant and uses for wound healing
EP3516045A1 (en) * 2016-09-23 2019-07-31 The United States of America, as represented by The Secretary, Department of Health and Human Services Methods of preparing an isolated population of dendritic cells and methods of treating cancer using same
CN111065400A (en) * 2017-10-03 2020-04-24 公益财团法人东京都医学总合研究所 Anti-influenza medicine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7713739B1 (en) 2000-11-17 2010-05-11 Novartis Vaccines And Diagnostics, Inc. Microparticle-based transfection and activation of dendritic cells
KR101131727B1 (en) 2004-06-11 2012-03-28 가톨릭대학교 산학협력단 DENDRITE CELLS TRANSDUCED WITH RECOMBINANT ADENOVIRUS AdVCEA WHICH GENERATE CEA-SPECIFIC CYTOTOXIC T LYMPHOCYTES, VACCINE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
EP1748067A1 (en) 2005-07-29 2007-01-31 Institut Pasteur Polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereof or polyepitopes
KR101548783B1 (en) 2009-03-05 2015-08-31 매크로큐어, 엘티디. Activated leukocyte composition

Also Published As

Publication number Publication date
MX2014010893A (en) 2015-06-23
CA2864838A1 (en) 2013-09-19
US20150071892A1 (en) 2015-03-12
JP2015509974A (en) 2015-04-02
EP2825182A1 (en) 2015-01-21
WO2013136191A1 (en) 2013-09-19
RU2014140795A (en) 2016-05-10

Similar Documents

Publication Publication Date Title
MX2017008819A (en) Anti-cd47 antibodies and uses thereof.
IN2012DN01920A (en)
TN2012000414A1 (en) Forms of rifaximin and uses thereof
IN2014CN04251A (en)
PT2750682T (en) Composition comprising anaerobically cultivated human intestinal microbiota
NZ629697A (en) Human anti-cd27 antibodies, methods and uses
MX2016008448A (en) Var2csa-drug conjugates.
MX2017001279A (en) Flagellin compositons and uses.
EA201391611A1 (en) CALLING IMMUNE TOLERANCE SYNTHETIC NON-CARRIERS FOR TREATMENT OF ALLERGY
ZA201307394B (en) Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
EA201300585A1 (en) Immunomodulatory Oligonucleotides
IN2014DN11201A (en)
ZA201500099B (en) Radiation-curable ,stable nail gel compositions and methods of preparation and use
IN2014DN06104A (en)
MX2015003701A (en) Treatment compositions.
HK1218880A1 (en) Compositions and methods of enhancing immune responses to eimeria or limiting eimeria infection
PL2892556T3 (en) Compositions and methods relating to the treatment of diseases
EA201401117A1 (en) COMPOSITIONS CONTAINING PROBIOTICS AND COMPLEX OF BEE POULTRY / CLAY, METHOD OF THEIR PREPARATION AND THEIR APPLICATION IN FOOD AND THERAPY
EP2878666A4 (en) Industrial preparation of natural killer cells (nks) and injection using human allogeneic karyocytes
IN2014DN08407A (en)
IN2014DN08093A (en)
MX2013014420A (en) Gel compositions.
AU346524S (en) Spacer
SG11201504779YA (en) Methods and compositions relating to treatment of cancer
EP2838543A4 (en) Immunostimulatory compositions and methods of manufacture